Condition: Solid Tumors · Sponsor: Bristol-Myers Squibb
This is an open-label, multicenter Phase 2 study evaluating BMS-986504 in participants with advanced and/or metastatic solid tumors that have MTAP deletion. The study includes a monotherapy component and a combination component in which BMS-986504 is given with other anti-cancer agents. The trial will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of BMS-986504 alone and in combination regimens.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0096 | San Francisco, California, United States | Not Yet Recruiting |
| Local Institution - 0182 | Aurora, Colorado, United States | Not Yet Recruiting |
| Local Institution - 0178 | Atlanta, Georgia, United States | Not Yet Recruiting |
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
| Local Institution - 0124 | Boston, Massachusetts, United States | Not Yet Recruiting |
| Local Institution - 0119 | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Local Institution - 0129 | Rochester, Minnesota, United States | Not Yet Recruiting |
| Local Institution - 0174 | Rochester, Minnesota, United States | Not Yet Recruiting |
| Local Institution - 0181 | Rochester, Minnesota, United States | Not Yet Recruiting |
| Local Institution - 0142 | Buffalo, New York, United States | Not Yet Recruiting |
| Local Institution - 0170 | New York, New York, United States | Not Yet Recruiting |
| Local Institution - 0139 | New York, New York, United States | Not Yet Recruiting |
+ 45 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.